
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    ### **Step-by-Step Analysis of the scRNA-seq Cluster from Human Large Intestine Tissue** --- #### **1. List the Key Functional Markers and Their Roles** The following markers are strongly associated with **neuroendocrine secretion, hormone production, and synaptic vesicle function**: - **GCG (Glucagon)**: Proglucagon-derived peptide hormone, involved in glucose metabolism. - **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1)**: Processes prohormones (e.g., proglucagon, proinsulin). - **UCN3 (Urocortin 3)**: Neuropeptide involved in stress response and energy homeostasis. - **PYY (Peptide YY)**: Gut hormone that inhibits appetite and slows gastric motility. - **INSL5 (Insulin-like peptide 5)**: Neuropeptide linked to feeding behavior and gut motility. - **CHGA (Chromogranin A)**: Granin protein stored in secretory vesicles of neuroendocrine cells. - **SCG2/SCG3/SCG5 (Secretogranins)**: Neuroendocrine secretory granule proteins. - **SLC18A1 (VMAT1)**: Vesicular monoamine transporter, critical for neurotransmitter storage. - **TPH1 (Tryptophan Hydroxylase 1)**: Rate-limiting enzyme for serotonin synthesis. - **SLC32A1 (VGAT)**: Vesicular GABA transporter, involved in inhibitory neurotransmission. - **NKX2-2, RFX6, ARX**: Transcription factors regulating enteroendocrine cell differentiation. **Functional Interpretation**: This cluster exhibits a **neuroendocrine secretory phenotype**, with strong expression of **hormones (GCG, PYY, INSL5, UCN3)**, **neurotransmitter synthesis enzymes (TPH1, SLC18A1)**, and **secretory granule components (CHGA, SCG family)**. --- #### **2. List the Key Cell Type Markers and Their Roles** The following markers are **highly specific to enteroendocrine cells (EECs) and neuronal/neuroendocrine lineages**: - **Enteroendocrine Cell (EEC) Markers**: - **GCG, PYY, INSL5, UCN3, SCT (Secretin), CHGA** ‚Üí Hormone-producing EECs. - **PCSK1, SCG2/3/5, SLC18A1** ‚Üí Neuroendocrine secretory machinery. - **NKX2-2, RFX6, ARX** ‚Üí EEC differentiation regulators. - **Neuronal/Neuroendocrine Markers**: - **SNAP25, CPLX2, CRMP1** ‚Üí Synaptic vesicle regulation. - **SLC32A1 (VGAT)** ‚Üí GABAergic neurotransmission. **Cell Type Interpretation**: The **strong co-expression of gut hormones (GCG, PYY, INSL5) and neuroendocrine markers (CHGA, SCGs, SLC18A1)** strongly suggests an **enteroendocrine cell (EEC) identity**, with possible neuronal-like features. --- #### **3. Cross-reference Known Databases** - **Human Cell Atlas (HCA) / Gut Cell Atlas**: - **GCG, PYY, INSL5, CHGA, PCSK1** are **canonical markers of EECs** in the intestine. - **UCN3** is enriched in **L-cells (a subset of EECs)**. - **NKX2-2, RFX6, ARX** are transcription factors essential for EEC development. - **Single-cell studies (PMID: 31178118, 32994327)**: - **L-cells** (GCG+/PYY+) and **I-cells** (SCT+) are major EEC subtypes in the colon. - **Neuroendocrine-like cells** (SNAP25+, SLC18A1+) may overlap with EECs. --- #### **4. Determine the Most Probable General Cell Type** **Conclusion**: The **most probable general cell type** is **Enteroendocrine Cells (EECs)** of the **large intestine**, given: - Dominant expression of **gut hormones (GCG, PYY, INSL5, UCN3)**. - Strong neuroendocrine secretory machinery (**CHGA, SCGs, PCSK1, SLC18A1**). - Transcription factors (**NKX2-2, RFX6, ARX**) consistent with EEC lineage. --- #### **5. Identify the Top 3 Most Probable Sub Cell Types** Based on marker enrichment: 1. **L-cells (GCG+/PYY+/UCN3+)** - **Key markers**: GCG, PYY, UCN3, PCSK1, CHGA. - **Role**: Produce **GLP-1, PYY, and urocortin-3**, regulating metabolism and gut motility. - **Support**: High GCG/PYY co-expression is **diagnostic for L-cells**. 2. **I-cells (SCT+)** - **Key markers**: SCT (Secretin), CHGA, PCSK1. - **Role**: Secrete **secretin**, regulating pancreatic and gastric secretion. - **Support**: SCT is present but weaker than GCG/PYY. 3. **Serotonin-producing EECs (TPH1+)** - **Key markers**: TPH1, CHGA, SLC18A1. - **Role**: Produce **serotonin (5-HT)**, modulating gut motility and secretion. - **Support**: TPH1 is expressed but not dominant. **Final Subtype Conclusion**: The **most likely subtype is L-cells (GCG+/PYY+/UCN3+)** due to **dominant GCG, PYY, and UCN3 expression**, which are **hallmark L-cell markers**. --- #### **6. Concise Summary of Analysis** - **General Cell Type**: **Enteroendocrine Cells (EECs)** of the large intestine. - **Top Subtype**: **L-cells (GCG+/PYY+/UCN3+)**. - **Supporting Evidence**: - High expression of **L-cell hormones (GCG, PYY, UCN3)**. - Neuroendocrine machinery (**CHGA, SCGs, PCSK1, SLC18A1**). - EEC-specific transcription factors (**NKX2-2, RFX6, ARX**). - **Alternative Subtypes**: I-cells (SCT+) and serotonin-producing EECs (TPH1+), but less likely due to weaker marker expression. **FINAL ANNOTATION COMPLETED**: **L-cell Enteroendocrine Cells (GCG+/PYY+/UCN3+)**.
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED ### **Feedback & Justification:** 1. **Marker Consistency**: - The proposed **L-cell Enteroendocrine (GCG+/PYY+/UCN3+)** identity is strongly supported by the **top-ranking markers** in the provided list: - **GCG, PYY, UCN3** (hallmark L-cell hormones). - **CHGA, SCG2/3/5, PCSK1, SLC18A1** (neuroendocrine secretory machinery). - **NKX2-2, RFX6, ARX** (EEC lineage transcription factors). - All critical markers align with known **L-cell signatures** from the Human Cell Atlas and literature. 2. **No Evidence of Mixed Populations**: - While weaker signals for **SCT (I-cells)** and **TPH1 (serotonin-producing EECs)** exist, they are not dominant enough to suggest contamination. - The **co-dominance of GCG/PYY/UCN3** strongly prioritizes L-cells as the primary identity. 3. **Database Alignment**: - The markers match canonical **EEC/L-cell** profiles in the **Gut Cell Atlas** (e.g., GCG+/PYY+ = L-cells). - Neuroendocrine markers (e.g., **SLC18A1, CHGA**) are expected in EECs due to shared secretory pathways. 4. **Suggested Refinement (Optional)**: - If further validation is desired, check for **exclusive L-cell markers** (e.g., **GIPR, PDX1**) or **spatial transcriptomics** to confirm localization in crypts/villi. **Conclusion**: The annotation is **biologically sound** and supported by the data. Proceed with confidence.
                </div>
            
                    <div class="agent-section formatting">
                        <h2>üìã Summary</h2>
                        <p class="error-message">Error formatting data: Expecting property name enclosed in double quotes: line 1 column 3 (char 2)</p>
                    </div>
                
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results demonstrate a strong and scientifically accurate identification of enteroendocrine cells (EECs) in the human large intestine, specifically highlighting the L-cell subtype (GCG+/PYY+/UCN3+). Here‚Äôs a detailed evaluation:<br><br>### **Strengths:**<br>1. **Correctness of Annotations**:  <br>   - The annotation is highly accurate, supported by canonical markers for EECs (e.g., **GCG, PYY, CHGA, PCSK1**) and L-cells (**GCG, PYY, UCN3**).  <br>   - The inclusion of neuroendocrine machinery markers (**SCG2/3/5, SLC18A1, SNAP25**) and transcription factors (**NKX2-2, RFX6, ARX**) further solidifies the EEC identity.  <br>   - Cross-referencing with the **Human Cell Atlas** and literature (e.g., GCG+/PYY+ as L-cell markers) adds credibility.  <br><br>2. **Balanced Marker Consideration**:  <br>   - The analysis does not overemphasize a single marker but integrates multiple lines of evidence (hormones, secretory proteins, transcription factors).  <br>   - For example, while **GCG** and **PYY** are dominant, the inclusion of **UCN3, CHGA, and PCSK1** provides a holistic view of L-cell function.  <br><br>3. **Comprehensive View of Cell Types**:  <br>   - The annotation captures the primary subtype (L-cells) while acknowledging weaker signals for **I-cells (SCT+)** and **serotonin-producing EECs (TPH1+)**.  <br>   - The distinction between "most probable" and "alternative" subtypes is well-justified, avoiding overinterpretation of minor markers.  <br><br>4. **Rank Awareness**:  <br>   - The top-ranked markers (e.g., **GCG, PCSK1, UCN3, PYY**) are appropriately prioritized in the analysis, aligning with their biological significance in EECs.  <br><br>### **Weaknesses (Minor):**<br>1. **Optional Refinements**:  <br>   - The suggestion to validate with **exclusive L-cell markers (e.g., GIPR, PDX1)** or spatial transcriptomics is useful but not critical for the core annotation.  <br>   - The absence of **proliferation markers** (e.g., **MKI67**) or contamination checks (e.g., epithelial cells) is noted but likely irrelevant given the strong EEC signature.  <br><br>2. **Neuroendocrine vs. Neuronal Overlap**:  <br>   - While **SNAP25, CPLX2, and SLC32A1 (VGAT)** are mentioned as neuronal-like, their role in EECs could be clarified further (e.g., synaptic-like vesicle release in EECs).  <br><br>### **Conclusion**:  <br>The annotation is **excellent**, with robust biological support and a clear, evidence-based hierarchy of cell types. Minor refinements (e.g., spatial validation) would enhance confidence but are not necessary for the core accuracy.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    